SCHEMBL6510696

SCHEMBL6510696

CCCCc1ccc(N=C(N)Nc2nc(C)cc(C)n2)c(C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.59
MAPK1 P28482 1/20 0.59
CYP2D6 P10635 3/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 1/20 0.49
CYP4Z1 Q86W10 1/20 0.49
CYP4F11 Q9HBI6 1/20 0.49
CYP4F12 Q9HCS2 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ADORA2A P29274 3/20 0.46
SKP2 Q13309 1/20 0.43
SIGMAR1 Q99720 4/20 0.40
LMNA P02545 1/20 0.40
HRH4 Q9H3N8 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513329 0.85 MAPK1 (0.53) RAB9AMAPK1CYP2D6CYP3A4CYP2C9
SCHEMBL6508890 0.83 LMNA (0.48) RAB9AMAPK1CYP2D6CYP3A4CYP2C9
SCHEMBL6510224 0.83 RAB9A (0.50) RAB9AMAPK1CYP2D6CYP3A4CYP2C9
SCHEMBL6507568 0.79 RAB9A (0.72) RAB9AMAPK1MEN1KMT2ANPC1
SCHEMBL5923165 0.73 MEN1 (0.46) RAB9AMAPK1CYP2D6CYP3A4CYP2C9
SCHEMBL10501633 0.71 ADORA2A (0.56) RAB9AMAPK1MEN1KMT2ANPC1
SCHEMBL10501630 0.71 ADORA2A (0.56) RAB9AMAPK1MEN1KMT2ANPC1
SCHEMBL6512568 0.71 CRHBP (0.53) RAB9AMAPK1CYP2C9CYP1A2CYP2C19
SCHEMBL14862522 0.70 RAC1 (0.52) RAB9AMAPK1MEN1KMT2ANPC1
SCHEMBL14861786 0.68 SIGMAR1 (0.65) RAB9AMEN1KMT2ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed